Global Autoimmune Disease Therapeutics Market Research Report: Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit According to a new report published by Allied Market Research, titled,”Autoimmune Disease Therapeutics Market by Drug Class, Indication, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018-2025,”the global autoimmune disease therapeutics market was valued at USD 109,833 million in 2017, and is expected to reach USD 153,320 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025. Autoimmune disease therapeutics include different types of drugs such as anti-inflammatory, antihyperglycemics, NSAIDs, interferons, immune suppressants, corticosteroids, beta-blockers, and others. The demand for autoimmune disease therapeutics is estimated to increase during the forecast period owing to surge in prevalence of autoimmune disease, advancement in screening & diagnosis procedures, and wide availability of advanced therapeutics. Moreover, strong presence of pipeline drugs such as tocilizumab, baricitinib, certolizumab, secukinumab, etanercept, olokizumab, abatacept, apremilast, PF-06438179, golimumab, ustekinumab, etrolizumab, tofacitinib, and others is expected to further boost the market growth. Based on drug class, the global autoimmune disease therapeutics market is segmented into anti-inflammatory, antihyperglycemics, NSAIDs, interferons, and others. Anti-inflammatory was the major revenue contributing segment in 2017, and is expected to maintain its dominance during the forecast period owing to increase in demand for anti- inflammatory drugs, launch of newer anti- inflammatory drugs with the supportive reimbursement policies for usage of advanced anti- inflammatory drugs in some countries. Moreover, expected launch of pipeline anti-inflammatories such as tocilizumab, certolizumab, secukinumab, etanercept, golimumab, and others, is estimated to further influence the market growth. Based on indication, the market is classified as rheumatic disease, type 1 diabetes, multiple sclerosis, inflammatory bowel disease, and other indications. Rheumatic disease segment accounted for a major share in 2017 and is expected to remain dominant during the forecast period owing to surge in prevalence of arthritis, fibromyalgia, systemic lupus erythematosus, gout, scleroderma, polymyalgia rheumatica and others, wide availability of advanced therapeutics for treatment of rheumatic disease, availability of advanced therapeutics for the treatment of these diseases. According to sales channel, the market is segmented into hospital pharmacies, drug stores & retail pharmacies, and online stores. Online providers segment is expected to experience rapid growth during the forecast period owing to rise in preference for online purchasing of drugs over the traditional methods and increase in awareness about online pharmacy with rise in number of internet users. On the other side, drug store & retail pharmacy segment is estimated to be the major revenue contributor due to massive presence of these pharmacies. Based on indication, the rheumatic disease segment held nearly half of the global market share in 2017, and is projected to grow at a CAGR of 5.2% from 2018 to 2025. Based on sales channel, the online stores segment is expected to experience rapid growth and is projected to grow at a CAGR of 6.8% during the forecast period 2018-2025. Depending on drug class, the anti-inflammatory segment accounted for nearly half of the global market share in 2017, and is projected to grow at a CAGR of 5.2% from 2018 to 2025. Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.3% during the forecast period. North America accounted for a major market share in 2017, and is expected to remain dominant throughout the forecast period. Higher prevalence of autoimmune disease, early diagnosis, easy availability of advanced therapeutics, strong presence of key players, favorable reimbursement in healthcare system, and higher number of trained medical professionals are key drivers of the North America autoimmune disease therapeutics market. On the other side, Asia-Pacific is expected to experience the highest growth rate during the forecast period owing to increase in number of target population, rise in adoption of therapeutics with development in healthcare infrastructure. For more information on the research report, refer to below link:- Global Autoimmune Disease Therapeutics Market Contact Us:- Ken Research Ankur Gupta, Head Marketing & Communications Ankur@kenresearch.com +91-9015378249 Post Views: 3 Tags: Abbott Laboratories Autoimmune Disease Therapeutics Market Size, AbbVie Autoimmune Disease Therapeutics Market Shares, Amgen Autoimmune Disease Therapeutics Market Revenue, Asia Pacific Autoimmune Disease Therapeutics Market, AstraZeneca Autoimmune Disease Therapeutics Market Shares, Australia Autoimmune Disease Therapeutics Market, Autoimmune Disease Therapeutics Industry In Global, Autoimmune Disease Therapeutics Market In Global, Brazil Autoimmune Disease Therapeutics Market, Bristol-Myers Squibb Autoimmune Disease Therapeutics Market Size, Canada Autoimmune Disease Therapeutics Market, China Autoimmune Disease Therapeutics Market, Europe Autoimmune Disease Therapeutics Market, F. Hoffmann-La Roche AG Autoimmune Disease Therapeutics Market Shares, France Autoimmune Disease Therapeutics Market, Germany Autoimmune Disease Therapeutics Market, Global Autoimmune Disease Therapeutics Anti Inflammatory Market, Global Autoimmune Disease Therapeutics Antihyperglycemics Market, Global Autoimmune Disease Therapeutics Drug Store Market, Global Autoimmune Disease Therapeutics Hospital Pharmacy Market, Global Autoimmune Disease Therapeutics Industry, Global Autoimmune Disease Therapeutics Industry Research Report, Global Autoimmune Disease Therapeutics Interferons Market, Global Autoimmune Disease Therapeutics Market, Global Autoimmune Disease Therapeutics Market Analysis, Global Autoimmune Disease Therapeutics Market Competition, Global Autoimmune Disease Therapeutics Market Forecast, Global Autoimmune Disease Therapeutics Market Future Outlook, Global Autoimmune Disease Therapeutics Market Growth, Global Autoimmune Disease Therapeutics Market Major Players, Global Autoimmune Disease Therapeutics Market Research Report, Global Autoimmune Disease Therapeutics Market Revenue, Global Autoimmune Disease Therapeutics Market Shares, Global Autoimmune Disease Therapeutics Market Size, Global Autoimmune Disease Therapeutics NSAIDs Market, Global Autoimmune Disease Therapeutics Online Store Market, Global Autoimmune Disease Therapeutics Retail Pharmacy Market, Global Inflammatory Bowel Disease Therapeutics Market, Global Rheumatic Disease Therapeutics Market, India Autoimmune Disease Therapeutics Market, Industry Research Report Of Global Autoimmune Disease Therapeutics, Italy Autoimmune Disease Therapeutics Market, Japan Autoimmune Disease Therapeutics Market, Johnson & Johnson Autoimmune Disease Therapeutics Market Revenue, Marché mondial des thérapies contre les maladies auto-immunes, Market Research Report Of Global Autoimmune Disease Therapeutics, Mexico Autoimmune Disease Therapeutics Market, North America Autoimmune Disease Therapeutics Market, Novartis AG Autoimmune Disease Therapeutics Market Sales, Pasar Terapi Penyakit Autoimun Global, Pfizer Autoimmune Disease Therapeutics Market Revenue, Saudi Arabia Autoimmune Disease Therapeutics Market, South Africa Autoimmune Disease Therapeutics Market, South Korea Autoimmune Disease Therapeutics Market, Spain Autoimmune Disease Therapeutics Market, U.S. Autoimmune Disease Therapeutics Market, UCB S.A Autoimmune Disease Therapeutics Market Sales, UK Autoimmune Disease Therapeutics Market, Глобальный рынок терапии аутоиммунными заболеваниями, السوق العالمية لعلاج أمراض المناعة الذاتية, ลาดการรักษาโรคภูมิต้านทานผิดปกติทั่วโลก, 世界の自己免疫疾患治療薬市場, 全球自身免疫疾病治疗市场